A comparative permeation/release study of different testosterone gel formulations

Drug Delivery

Volumn 14, Issue 6, 2007, Pages 389-396

  Pabla, Dimple ^a   Zia, Hossein ^a  

^a UNIVERSITY OF RHODE ISLAND   (United States)

Author keywords

Androgel ; Hydroalcoholic Gels; Penetration Enhancement; Testosterone; Transdermal Gel

Indexed keywords

2 PROPANOL; CARBOMER; TESTOSTERONE;

ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; DRUG PENETRATION; DRUG RELEASE; DRY SKIN; GUINEA PIG; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; ULTRAVIOLET RADIATION;

2-PROPANOL; ADMINISTRATION, CUTANEOUS; ANALYSIS OF VARIANCE; ANDROGENS; ANIMALS; BIOLOGICAL AVAILABILITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG DELIVERY SYSTEMS; GELS; GUINEA PIGS; MALE; MEMBRANES, ARTIFICIAL; PERMEABILITY; PHARMACEUTIC AIDS; SKIN ABSORPTION; SOLVENTS; SPECTROPHOTOMETRY, ULTRAVIOLET; TESTOSTERONE;

EID: 34547927613     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.1080/10717540701203075     Document Type: Article

References (32)

1. Bals-Pratsch, M., Knuth, U. A., Yoon, Y. D., and Nieschlad, E. 1986. Transdermal testosterone substitution therapy for male hypogonadism. Lancet 2:943-946.
2. Berner, B., Mazzenga, G. C., Otte, J. H., Steffens, R. J., Juang, R. H., and Ebert, C. D. 1989. Ethanol:water mutually enhanced transdermal therapeutic system II: skin permeation of ethanol and nitroglycerin. J. Pharm. Sci. 78:402-407.
3. Chan, T. C. 2005. Percutaneous penetration enhancers: an update. Biennial Int Conf Perspect Percutaneous Penetration 9:18-22.
4. Cunningham, G. R., Cordero, E., and Thornby, J. I. 1989. Testosterone replacement with trandermal therapeutic systems. Physiological serum testosterone and elevated dihydrotestosterone levels. J Am. Med. Assoc. 261:2525-2530.
5. Dobs, A. S., Meikle, A. W., Arver, S. Sanders, S. W., Caramelli, K. E., and Mazer, N. A. 1999. Pharmacokinetics, efficacy, and safety of a permeation-enhanced testosterone transdermal system in comparison with bi-weekly injections of testosterone enanthate for the treatment of hypogonadal men. J. Clin. Endoc. Metab. 84:3469-3478.
6. Dudley, R. E., Kottayil, S. G., and Palatchi, O. 2003. Pharmaceutical composition and method for treating hypogonadism. U.S. Patent 651777[6,503,894].
7. HIV Hotline. 1998. Hepatic effects of 17 alpha-alkylated anabolic-androgenic steroids. 8:2-5.
8. Jockenhovel, F. 2004. Testosterone therapy - what, when and to whom?. Aging Male 7:319-324.
9. Jordan, W. P. 1997. Allergy and topical irritation associated with transdermal testosterone administration: a comparison of scrotal and nonscrotal transdermal systems. Am. J. Contact Dermatitis 8:108-113.
10. Ko, K. T., Needham, T. E., and Zia, H. 1998. Emulson formulations of testosterone for nasal administration. J. Microencap. 15:197-205.
11. Kurihara-Bergstrom, T., Knutson, K., DeNoble, L. J., and Goates, C. Y. 1990. Percutaneous absorption enhancement of an ionic molecule by ethanol:water systems in human skin. Pharm. Res. 7:762-766.
12. Mackey, M. A., Conway, A. J., and Handelsman D. J. 1995. Tolerability of intramuscular injections of testosterone ester in oil vehicle. Hum. Reprod. 10:862-865.
13. MacLean-McDavitt, D. S., Robertson, J. D., and Jay, M. 2003. Monitoringthe in vitro delivery of proteins from carbomer hydrogels by x-ray fluorescence. Pharmaceutical Research. 20:435-441.
14. The Medical Letter, Inc. 2000. Androgel®. Medical Letter on Drug Therapies. 42(1080):49-52.
15. Meikle, A. W., Arver, S., Dobs, A. S., Sanders, S. W., Rajaram, L., and Mazer, N. A. 1996. Pharmacokinetics and metabolism of a permeation-enhanced testosterone transdermal system in hypogonadal men: influence of application site-a clinical research center study. J. Clin. Endocrin. Metab. 81:1832-1840.
16. Montgomery, D. C. 1991. Design and Analysis of Experiments. New York: John Wiley and Sons.
17. Morales, A. and Lunenfeld, B. 2002. Investigation, treatment and monitoring of late-onset hypogonadism in males. Aging Male 5:74-86.
18. Mortazavi, S. A., and Aboofazeli, R. 2003. An investigation into the effect of carbopols on the release of propranolol HCI from tablet matrices. Iranian J. Pharm. Res. 1:23-27.
19. Noveon 2001. Polymers in Semisolid Products. Cleveland: Noveon Inc. Retrieved on 05/12/04. http://www.pharma.noveon.com/literature/ default.asp.
20. Noveon 2002a. Carbopol Ultrez 10 Polymer for Personal Care. Cleveland: Noveon, Inc, Retrieved on 05/12/04. http://www.pharma.noveon.com/ literature/default.asp#Tech.
21. Noveon 2002b. Product and Regulatory Guide. Cleveland: Noveon, Inc. Retrieved on 05/12/04. http://www.pharma.noveon.com/literature/ default.asp.
22. Pershing, L. K., Lambert, L. D., and Knutson, K. 1990. Mechanism of ethanolenhanced estradiol permeation across human skin in vivo. Pharm. Res. 7:170-175.
23. Schulte-Beerbuhl, M., and Nieschlag, E. 1980. Comparison of testosterone, dihydrotestosterone, luteinizing hormone, and follicle-stimulating hormone in serum after injection of testosteron enanthate and testosterone cypionate. Ferti. Steril. 33:201-203.
24. Schurmeyer, T., and Nieschlag, E. 1984. Comparative pharmacokinetics of testosterone enanthate and testosterone cyclohexanecarboxylate as assessed by serum and salivary testosterone levels in normal men. Int. J. Androl. 7: 181-187.
25. Swerdloff, R. S., Wang, C., Cunningham, G., Dobs, A, Iranmanesh, A., Matsmoto, A. M., Snyder, P. J., Weber, T., Longstreth, J., and Berman, N. 2000. Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men. J. Clin. Endocrin. Metab. 85:4500-4510.
26. Tan, C. Y., Statham, B., Marks, R., and Payne, P. A. 1982. Skin thickness measurement by pulsed ultrasound: its reproducibility, validation and variability. Br. J. Dermatol. 106:657-667.
27. Tenover, J. L. 1998. Male hormone replaement therapy including "andropause. Endocrin. Metab. Clin. N. Am. 27:969-987.
28. Thomas, N. S., and Panchagnula, R. 2003. Transdermal deliery of zidovudine: effect of vehicles on permeation across rat skin and their mechanism of action. Eur. J. Pharm. Sci. 18:71-79.
29. Tripathi, K. D. 2000. Essentials of Medical Pharmacology. New Delhi, India: Jaypee Brothers Medical Publishers (P) Ltd., 298-325.
30. Wang, C., Berman, N., Longstreth, J. A., Chuapoco, B., Hull, L, Steiner, B., Faulkner, S., Dudley, R. E., and Swerdloff, R.S. 2000. Pharmacokinetics of transdermal testosterone gel in hypogonadal men: application of gel at one site vesus four sites: a general clinical research center study. J. Clin. Endocrin. Metab. 85:964-969.
31. Williams, A. C., and Barry, B. W. 2004. Penetration enhancers. Adv. Drug Del Rev. 56:603-618.
32. Wilson, J. D. 1990. Goodman and Gilman's The Pharmacological Basis of Therapeutics. Columbus, Ohio: Pregamon Press, 1413.